Duchenne Muscular Dystrophy (DMD) is a rare, inherited neuromuscular disorder that primarily affects boys. It causes progressive muscle weakness and degeneration due to the absence of a protein called dystrophin, which is essential for healthy muscle function. DMD typically appears in early childhood and gradually worsens over time, affecting the muscles used for movement, breathing, and heart function.
DMD is caused by mutations in the dystrophin gene, located on the X chromosome. Since males have only one X chromosome, the absence of a functioning dystrophin gene leads to the development of the disease. Females are usually carriers and may not show symptoms, although in rare cases they can have mild muscle weakness.
Symptoms usually begin between ages 2 and 5 and may include:
As the condition progresses, most children with DMD lose the ability to walk by their early teens and require a wheelchair. Eventually, the muscles that control breathing and the heart are affected.
DMD is diagnosed through a combination of:
There is currently no cure for DMD, but early intervention and supportive care can improve quality of life and extend life expectancy. Management includes:
Medical Treatment:
Rehabilitation and Supportive Care: